Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

GLAUKOS CORP.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1998-01-01

Employees: 907

Market Cap: $7.4B

Website: http://www.glaukos.com

Clinical Trials

Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Phase 3

Completed

Conditions: Keratoconus

Interventions: Drug: placebo solution
Drug: riboflavin solution
Device: KXL System

First Posted Date: 2011-04-29

Last Posted Date: 2021-04-26

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 236

Registration Number: NCT01344187

Locations: 🇺🇸
UC Irvine Department of Ophthalmology, Irvine, California, United States
🇺🇸
Bascolm Palmer Eye Institute, Miami, Florida, United States
🇺🇸
Emory Eye Center, Atlanta, Georgia, United States

and more 7 locations

Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents

Phase 4

Completed

Conditions: Subjects With Primary Open-angle Glaucoma (POAG)

Interventions: Device: iStent

First Posted Date: 2010-12-03

Last Posted Date: 2017-12-18

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 40

Registration Number: NCT01252862

Locations: 🇦🇲
S.V. Malayan's Ophthalmology Centre, Yerevan, Armenia

A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent

Phase 4

Completed

Conditions: Subject With Primary Open-angle Glaucoma (POAG)

Interventions: Device: iStent Supra Stent

First Posted Date: 2010-12-03

Last Posted Date: 2022-09-07

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 80

Registration Number: NCT01252914

Locations: 🇦🇲
S.V. Malayan Ophthalmology Centre, Yerevan, Armenia

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Not Applicable

Completed

Conditions: Primary Open Angle Glaucoma (POAG)

Interventions: Device: iStent

First Posted Date: 2010-12-03

Last Posted Date: 2022-08-31

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 119

Registration Number: NCT01252849

Locations: 🇦🇲
S.V. Malayan's Ophthalmology Centre, Yerevan, Armenia

Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents

Phase 4

Completed

Conditions: Subjects With Primary Open-angle Glaucoma (POAG)

Interventions: Device: iStents

First Posted Date: 2010-12-03

Last Posted Date: 2022-09-07

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 39

Registration Number: NCT01252888

Locations: 🇦🇲
S.V. Malayna's Ophthalmology Centre, Yerevan, Armenia

Feasibility Study of the Vedera KXS for Treatment of Keratoconus

Not Applicable

Completed

Conditions: Keratoconus

Interventions: Device: Vedera KXS

First Posted Date: 2010-02-17

Last Posted Date: 2021-04-26

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 23

Registration Number: NCT01069848

Locations: 🇹🇷
Beyoglu Eye Hospital, Istanbul, Turkey

GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma

Phase 3

Completed

Conditions: Glaucoma

Interventions: Procedure: Cataract Surgery
Device: iStent Inject (GTS400)

First Posted Date: 2010-01-20

Last Posted Date: 2015-05-19

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 164

Registration Number: NCT01052558

Locations: 🇺🇸
Boozman-Hof Regional Eye Clinic, Rogers, Arkansas, United States
🇺🇸
North Bay Eye Associates, Inc., Petaluma, California, United States
🇺🇸
Glaucoma Consultants of Colorado, Parker, Colorado, United States

and more 19 locations

Clinical Evaluation of the Vedera KXS for the Treatment of Spherical Myopia

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Vedera KXS

First Posted Date: 2009-06-19

Last Posted Date: 2021-04-26

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 40

Registration Number: NCT00925041

Locations: 🇹🇷
Beyoglu Eye Research and Education Hospital, Istanbul, Turkey

A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma

Phase 4

Completed

Conditions: Glaucoma, Open-Angle
Eye Diseases
Glaucoma

Interventions: Device: iStent

First Posted Date: 2009-06-03

Last Posted Date: 2015-05-20

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 112

Registration Number: NCT00911924

Locations: 🇦🇲
S.V. Malayan's Ophtalmology Centre, Yerevan, Armenia
🇦🇹
Allgemeines Krankenhaus Wien, Wien, Austria
🇫🇷
Chu de Lyon Hospital Edouard Herriot, Lyon, France

and more 10 locations

Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)

Phase 4

Completed

Conditions: Eye Diseases
Glaucoma
Glaucoma, Open-Angle

Interventions: Device: iStent
Drug: latanoprost/timolol

First Posted Date: 2009-06-03

Last Posted Date: 2015-05-20

Lead Sponsor: Glaukos Corporation

Target Recruit Count: 192

Registration Number: NCT00913029

Locations: 🇦🇲
SV Malayan Ophthalmological Center, Yerevan, Armenia
🇦🇹
Allgemeines Krankenhaus Wien, Wien, Austria
🇫🇷
CHU de Lyon Hopital Edouard Herriot, Lyon, France

and more 13 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy